Exploring the Photolysis Pathways of Acetone Relevant to the Troposphere

The major and minor photochemical pathways of acetone have been studied to assess their prevalence in the atmosphere. Fourier transform infrared spectroscopy was used to obtain quantum yields of the photolysis products of acetone from 285 – 325 nm at various pressures of synthetic air and nitrogen bath gas (3-760 Torr total pressure). The two major pathways of acetone photolysis, Norrish Type I and triple fragmentation, were studied in neat conditions through primary (carbon monoxide) and secondary (biacetyl and ethane) products. These experiments found no evidence for the triple fragmentation pathway at wavelengths longer than 290 nm, which is in agreement with papers studying the pathway at shorter wavelengths. In oxygen-free conditions, biacetyl and ethane, both secondary products of the Norrish type I pathway, were found at different ratios depending on the photolysis wavelength, indicating an additional photolysis pathway forming ethane. Velocity map imaging of the carbon monoxide photofragment at photolysis wavelengths longer than 300 nm, combined with laser-induced fluorescence of acetone, found carbon monoxide was forming from a unimolecular pathway, attributed to roaming. Carbon monoxide was found to have a quantum yield of up to 10% in non-oxidative conditions at 3 Torr and 760 Torr. In an atmosphere of synthetic air at actinic wavelengths, this pathway was reduced to a maximum of 3%. The minor photolysis pathway forming ketene and methane was also studied and found to have a maximum quantum yield of 4\% in non-oxidative environments. The addition of oxygen reduced the quantum yield of ketene, indicating a secondary, radical pathway forming ketene. At atmospheric pressures of synthetic air, 1.5% was the highest quantum yield obtained. Propen-2-ol was detected in a 3 Torr neat acetone experiment at 310 nm and calculated to have a quantum yield of 4±2%. Due to the quick loss of propen-2-ol to wall-catalysed tautomerisation, a quantum yield was not assigned to the propen-2-ol pathway in other experimental conditions. These experiments showed that the molecular pathways of acetone become significant pathways in non-oxidative conditions at actinic wavelengths, both at low pressure and atmospheric pressure. In oxidative conditions these molecular ground state pathways become minor, with the radical Norrish type I pathway the major pathway

Computational Infrared Spectroscopy of 958 Phosphorus-Bearing Molecules

Phosphine is now well-established as a biosignature, which has risen to prominence with its recent tentative detection on Venus. To follow up this discovery and related future exoplanet biosignature detections, it is important to spectroscopically detect the presence of phosphorus-bearing atmospheric molecules that could be involved in the chemical networks producing, destroying or reacting with phosphine. We start by enumerating phosphorus-bearing molecules (P-molecules) that could potentially be detected spectroscopically in planetary atmospheres and collecting all available spectral data. Gaseous P-molecules are rare, with speciation information scarce. Very few molecules have high accuracy spectral data from experiment or theory; instead, the best current spectral data was obtained using a high-throughput computational algorithm, RASCALL, relying on functional group theory to efficiently produce approximate spectral data for arbitrary molecules based on their component functional groups. Here, we present a high-throughput approach utilizing established computational quantum chemistry methods (CQC) to produce a database of approximate infrared spectra for 958 P-molecules. These data are of interest for astronomy and astrochemistry (importantly identifying potential ambiguities in molecular assignments), improving RASCALL's underlying data, big data spectral analysis and future machine learning applications. However, this data will probably not be sufficiently accurate for secure experimental detections of specific molecules within complex gaseous mixtures in laboratory or astronomy settings. We chose the strongly performing harmonic ωB97X-D/def2-SVPD model chemistry for all molecules and test the more sophisticated and time-consuming GVPT2 anharmonic model chemistry for 250 smaller molecules. Limitations to our automated approach, particularly for the less robust GVPT2 method, are considered along with pathways to future improvements. Our CQC calculations significantly improve on existing RASCALL data by providing quantitative intensities, new data in the fingerprint region (crucial for molecular identification) and higher frequency regions (overtones, combination bands), and improved data for fundamental transitions based on the specific chemical environment. As the spectroscopy of most P-molecules have never been studied outside RASCALL and this approach, the new data in this paper is the most accurate spectral data available for most P-molecules and represent a significant advance in the understanding of the spectroscopic behavior of these molecules.</jats:p

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Background Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear. Methods RADICALS-HD was an international randomised controlled trial to test the efficacy of ADT used in combination with postoperative radiotherapy for prostate cancer. Key eligibility criteria were indication for radiotherapy after radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to radiotherapy alone (no ADT) or radiotherapy with 6 months of ADT (short-course ADT), using monthly subcutaneous gonadotropin-releasing hormone analogue injections, daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as distant metastasis arising from prostate cancer or death from any cause. Standard survival analysis methods were used, accounting for randomisation stratification factors. The trial had 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 80% to 86% (hazard ratio [HR] 0·67). Analyses followed the intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov, NCT00541047. Findings Between Nov 22, 2007, and June 29, 2015, 1480 patients (median age 66 years [IQR 61–69]) were randomly assigned to receive no ADT (n=737) or short-course ADT (n=743) in addition to postoperative radiotherapy at 121 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 9·0 years (IQR 7·1–10·1), metastasis-free survival events were reported for 268 participants (142 in the no ADT group and 126 in the short-course ADT group; HR 0·886 [95% CI 0·688–1·140], p=0·35). 10-year metastasis-free survival was 79·2% (95% CI 75·4–82·5) in the no ADT group and 80·4% (76·6–83·6) in the short-course ADT group. Toxicity of grade 3 or higher was reported for 121 (17%) of 737 participants in the no ADT group and 100 (14%) of 743 in the short-course ADT group (p=0·15), with no treatment-related deaths. Interpretation Metastatic disease is uncommon following postoperative bed radiotherapy after radical prostatectomy. Adding 6 months of ADT to this radiotherapy did not improve metastasis-free survival compared with no ADT. These findings do not support the use of short-course ADT with postoperative radiotherapy in this patient population

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

Background Previous evidence supports androgen deprivation therapy (ADT) with primary radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer. However, the use and optimal duration of ADT with postoperative radiotherapy after radical prostatectomy remains uncertain. Methods RADICALS-HD was a randomised controlled trial of ADT duration within the RADICALS protocol. Here, we report on the comparison of short-course versus long-course ADT. Key eligibility criteria were indication for radiotherapy after previous radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to add 6 months of ADT (short-course ADT) or 24 months of ADT (long-course ADT) to radiotherapy, using subcutaneous gonadotrophin-releasing hormone analogue (monthly in the short-course ADT group and 3-monthly in the long-course ADT group), daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as metastasis arising from prostate cancer or death from any cause. The comparison had more than 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 75% to 81% (hazard ratio [HR] 0·72). Standard time-to-event analyses were used. Analyses followed intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov , NCT00541047 . Findings Between Jan 30, 2008, and July 7, 2015, 1523 patients (median age 65 years, IQR 60–69) were randomly assigned to receive short-course ADT (n=761) or long-course ADT (n=762) in addition to postoperative radiotherapy at 138 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 8·9 years (7·0–10·0), 313 metastasis-free survival events were reported overall (174 in the short-course ADT group and 139 in the long-course ADT group; HR 0·773 [95% CI 0·612–0·975]; p=0·029). 10-year metastasis-free survival was 71·9% (95% CI 67·6–75·7) in the short-course ADT group and 78·1% (74·2–81·5) in the long-course ADT group. Toxicity of grade 3 or higher was reported for 105 (14%) of 753 participants in the short-course ADT group and 142 (19%) of 757 participants in the long-course ADT group (p=0·025), with no treatment-related deaths. Interpretation Compared with adding 6 months of ADT, adding 24 months of ADT improved metastasis-free survival in people receiving postoperative radiotherapy. For individuals who can accept the additional duration of adverse effects, long-course ADT should be offered with postoperative radiotherapy. Funding Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society

Input and output files supporting Extension, Development and Evaluation of the representation of the OH-initiated DMS oxidation mechanism in the MCM v3.3.1 framework

The input files for the 0D box modelling of the experiments (through BOXMOX), along with the output files for the mechanism developed in this study. A README.txt file is also included that describes the files, and how to use them

Extension, Development and Evaluation of the representation of the OH-initiated DMS oxidation mechanism in the MCM v3.3.1 framework

Understanding dimethyl sulfide (DMS) oxidation can help us constrain its contribution to Earth’s radiative balance. Following the discovery of hydroperoxymethyl thioformate (HPMTF) as a DMS oxidation product, a range of new experimental chamber studies have since improved our knowledge of the oxidation mechanism of DMS and delivered detailed chemical mechanisms. However, these mechanisms have not undergone formal intercomparisons to evaluate their performance. This study aimed to synthesise the recent experimental studies and develop a new, near-explicit, DMS mechanism, through a thorough literature review. A simple box model was then used with the mechanism to simulate a series of chamber experiments, and evaluated through comparison with four published mechanisms. Our modelling shows that the mechanism developed in this work outperformed the other mechanisms on average when compared to the experimental chamber data, having the lowest fractional gross error for 8 out of the 14 DMS oxidation products studied. A box model of a marine boundary layer was also run, demonstrating that the deviations in the mechanisms seen when comparing them against chamber data are also prominent under more atmospherically relevant conditions. Although this work demonstrates the need for further experimental work, the mechanism developed in this work has been evaluated against a range of experiments, which validate the mechanism, and reduce the bias from individual experiments. Our mechanism provides a good basis for a near-explicit DMS oxidation mechanism that would include other initiation reactions (e.g., halogens), and can be used to compare the performance of reduced mechanisms used in global models.Cambridge Australia Scholarships and Cambridge Trus

Developing a Plan for a Comprehensive Sidewalk System in Monteverde, Costa Rica

Monteverde, Costa Rica, is a small community that is lacking a standardized sidewalk system, which can increase the risk of pedestrian-motor accidents. Our team used semi-structured interviews, participant observation, and content analysis to examine this issue. This project provided initial tools to expand coordination efforts across multiple sectors. We executed a town hall with landowners, provided recommendations to the municipality, and designed a landowner manual.Through developing a comprehensive sidewalk system, Monteverde can increase the safety of residents and tourists